.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Julphar
Mallinckrodt
Fish and Richardson
Cipla
Chubb
McKinsey
Teva
Daiichi Sankyo
US Department of Justice
Harvard Business School

Generated: September 26, 2017

DrugPatentWatch Database Preview

LOTRIMIN ULTRA Drug Profile

« Back to Dashboard

What is the patent landscape for Lotrimin Ultra, and what generic Lotrimin Ultra alternatives are available?

Lotrimin Ultra is a drug marketed by Bayer Healthcare Llc and is included in one NDA.

The generic ingredient in LOTRIMIN ULTRA is butenafine hydrochloride. There are two drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the butenafine hydrochloride profile page.

Summary for Tradename: LOTRIMIN ULTRA

Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: see list1
Bulk Api Vendors: see list79
Clinical Trials: see list244
Patent Applications: see list240
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:LOTRIMIN ULTRA at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bayer Healthcare Llc
LOTRIMIN ULTRA
butenafine hydrochloride
CREAM;TOPICAL021307-001Dec 7, 2001OTCYesYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Citi
UBS
US Department of Justice
Fish and Richardson
Farmers Insurance
Federal Trade Commission
Baxter
US Army
Queensland Health
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot